Embecta Corp. is managing challenges in a shifting environment.
Embecta Corp. is managing changes in its business environment.
Embecta Corp. is managing challenges in a shifting environment. Read More »
EMBC
Embecta, a company that specializes in diabetes devices, is considering the possibility of being sold due to declining profits.
The largest producer of insulin pen needles and syringes has seen a 70% decrease in its shares since being separated.
Zimmer Biomet has announced the appointment of Devdatt Kurdikar to its Board of Directors.
Zimmer Biomet has announced the appointment of Devdatt Kurdikar to their Board of Directors.
